Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.

Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A.

PLoS One. 2011;6(7):e22118. doi: 10.1371/journal.pone.0022118. Epub 2011 Jul 11.

PMID:
21779382
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.

Prostate. 2008 Feb 15;68(3):269-80. doi: 10.1002/pros.20699.

PMID:
18163422
[PubMed - indexed for MEDLINE]
3.

Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.

Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L, Yang Z, Xia Z.

Int J Biol Sci. 2013 May 15;9(5):472-9. doi: 10.7150/ijbs.5855. Print 2013.

PMID:
23781140
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.

Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.

Cancer Res. 2011 Dec 1;71(23):7226-37. doi: 10.1158/0008-5472.CAN-10-4660. Epub 2011 Sep 7.

PMID:
21900397
[PubMed - indexed for MEDLINE]
Free Article
5.

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.

Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD.

Cancer Res. 2010 Dec 1;70(23):9937-48. doi: 10.1158/0008-5472.CAN-10-0881. Epub 2010 Nov 30.

PMID:
21118965
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.

J Cell Mol Med. 2009 Aug;13(8B):2236-52. doi: 10.1111/j.1582-4934.2008.00455.x. Epub 2008 Aug 4.

PMID:
18681906
[PubMed - indexed for MEDLINE]
7.

Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.

Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM, Sethi G.

J Mol Med (Berl). 2011 Jul;89(7):713-27. doi: 10.1007/s00109-011-0746-2. Epub 2011 Apr 5.

PMID:
21465181
[PubMed - indexed for MEDLINE]
8.

STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.

Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T, Lin J.

Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):246-51. doi: 10.1016/j.bbrc.2011.10.112. Epub 2011 Oct 31.

PMID:
22074823
[PubMed - indexed for MEDLINE]
9.

Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.

Lin L, Liu Y, Li H, Li PK, Fuchs J, Shibata H, Iwabuchi Y, Lin J.

Br J Cancer. 2011 Jul 12;105(2):212-20. doi: 10.1038/bjc.2011.200. Epub 2011 Jun 21.

PMID:
21694723
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Metformin targets ovarian cancer stem cells in vitro and in vivo.

Shank JJ, Yang K, Ghannam J, Cabrera L, Johnston CJ, Reynolds RK, Buckanovich RJ.

Gynecol Oncol. 2012 Nov;127(2):390-7. doi: 10.1016/j.ygyno.2012.07.115. Epub 2012 Aug 2.

PMID:
22864111
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.

van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, Lorenzon G, Heckmann B, Feyen J, Pujuguet P, Blanque R, Clément-Lacroix P, van der Pluijm G.

Neoplasia. 2011 Jun;13(6):516-25.

PMID:
21677875
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, DeLeo AB, Wang X.

Clin Cancer Res. 2011 Oct 1;17(19):6174-84. doi: 10.1158/1078-0432.CCR-11-1111. Epub 2011 Aug 19.

PMID:
21856769
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
[PubMed - indexed for MEDLINE]
14.

Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells.

Don-Doncow N, Escobar Z, Johansson M, Kjellström S, Garcia V, Munoz E, Sterner O, Bjartell A, Hellsten R.

J Biol Chem. 2014 Jun 6;289(23):15969-15978. Epub 2014 Apr 22.

PMID:
24755219
[PubMed - as supplied by publisher]
15.

Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.

Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, Lü J.

Mol Cancer Ther. 2008 Sep;7(9):2681-91. doi: 10.1158/1535-7163.MCT-08-0456. Erratum in: Mol Cancer Ther. 2008 Nov;7(11):3654.

PMID:
18790750
[PubMed - indexed for MEDLINE]
Free Article
16.

Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.

Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, Lo WL, Tseng LM, Hsu HS, Chang KW, Chiou SH.

Mol Cancer Ther. 2010 Nov;9(11):2879-92. doi: 10.1158/1535-7163.MCT-10-0504. Epub 2010 Nov 9.

PMID:
21062915
[PubMed - indexed for MEDLINE]
Free Article
17.

Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.

Moreb JS, Zucali JR, Ostmark B, Benson NA.

Cytometry B Clin Cytom. 2007 Jul;72(4):281-9.

PMID:
17111384
[PubMed - indexed for MEDLINE]
Free Article
18.

Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, Ferrini S, Chouaib S, Vazquez A, Charpentier B, Camussi G, Azzarone B, Eid P.

J Natl Cancer Inst. 2011 Dec 21;103(24):1884-98. doi: 10.1093/jnci/djr451. Epub 2011 Oct 31.

PMID:
22043039
[PubMed - indexed for MEDLINE]
Free Article
19.

Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.

Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA.

Stem Cells. 2012 Nov;30(11):2366-77. doi: 10.1002/stem.1219.

PMID:
22961641
[PubMed - indexed for MEDLINE]
Free Article
20.

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.

Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.

Neoplasia. 2010 Jan;12(1):39-50.

PMID:
20072652
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk